Halo Labs Inc

Company Profile

Halo Labs Inc had its IPO on under the ticker symbol HCAND.

The company operates in the Healthcare sector and Healthcare Providers & Services industry. Halo Labs Inc has a staff strength of 276 employees.

Stock update

Shares of Halo Labs Inc opened at $0.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.02, and closed at $0.02.

This is a +14.58% increase from the previous day's closing price.

A total volume of 35,542 shares were traded at the close of the day’s session.

In the last one week, shares of Halo Labs Inc have slipped by -30.38%.

Halo Labs Inc's Key Ratios

Halo Labs Inc has a market cap of $1.23 million, indicating a price to book ratio of 0.0103 and a price to sales ratio of 0.0435.

In the last 12-months Halo Labs Inc’s revenue was $28.34 million with a gross profit of $4.45 million and an EBITDA of $-33465188. The EBITDA ratio measures Halo Labs Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Halo Labs Inc’s operating margin was -126.68% while its return on assets stood at -16.5% with a return of equity of -97.45%.

In Q3, Halo Labs Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 36.6%.

Halo Labs Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-3.045 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Halo Labs Inc’s profitability.

Halo Labs Inc stock is trading at a EV to sales ratio of 0.6382 and a EV to EBITDA ratio of -0.2047. Its price to sales ratio in the trailing 12-months stood at 0.0435.

Halo Labs Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$110.97 million

Total Liabilities

$18.43 million

Operating Cash Flow

$-29797.00

Capital Expenditure

$29797

Dividend Payout Ratio

0%

Halo Labs Inc ended 2024 with $110.97 million in total assets and $0 in total liabilities. Its intangible assets were valued at $110.97 million while shareholder equity stood at $80.19 million.

Halo Labs Inc ended 2024 with $0 in deferred long-term liabilities, $18.43 million in other current liabilities, 273080293.00 in common stock, $-209538161.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.71 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $10.51 million.

Halo Labs Inc’s total current assets stands at $34.89 million while long-term investments were $21.81 million and short-term investments were $0. Its net receivables were $7.44 million compared to accounts payable of $12.31 million and inventory worth $16.47 million.

In 2024, Halo Labs Inc's operating cash flow was $-29797.00 while its capital expenditure stood at $29797.

Comparatively, Halo Labs Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.02

52-Week High

$0.4575

52-Week Low

$0.0144

Analyst Target Price

$

Halo Labs Inc stock is currently trading at $0.02 per share. It touched a 52-week high of $0.4575 and a 52-week low of $0.4575. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.06 and 200-day moving average was $3.33 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 2318.2% of the company’s stock are held by insiders while 0% are held by institutions.